Current Opinion in Pulmonary Medicine was launched in 1995. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of pulmonary medicine is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Lee BrownLee BrownLee Brown received the SB (1972) in Electrical Engineering from the Massachusetts Institute of Technology, USA and the MD (1976) from the Mount Sinai School of Medicine of the City University of New York, USA. He is a tenured Professor of Internal Medicine and holds a secondary appointment as a Professor of Pediatrics in the School of Medicine; renewal is pending of a secondary appointment as a Professor of Electrical and Computer Engineering in the School of Engineering. He is board certified in Internal Medicine, Pulmonary Disease, and Sleep Medicine. His research interests include photo-biological applications to human disease and performance; circadian rhythm disorders; novel treatments for sleep disordered breathing; other sleep disorders; pulmonary and sleep physiology; and pleural disease. He previously held faculty positions at the Mount Sinai School of Medicine and the University of Arizona College of Medicine, USA. He is a member of the Eta Kappa Nu, Tau Beta Pi, and Sigma Xi honorary societies. He is listed in Castle Connolly “Top Doctors” for Sleep Medicine and Pulmonary Medicine, and won the Outstanding Clinician Award from the New Mexico Thoracic Society. He received the Alfred Soffer Award for Editorial Excellence from the American College of Chest Physicians (ACCP) in 2003. He has served on the Boards of Directors or Trustees of the American Thoracic Society (ATS), the American Academy of Sleep Medicine (AASM), the American Sleep Medicine Foundation, the American Board of Sleep Medicine, the Associated Professional Sleep Societies LLC, and the Greater Albuquerque Medical Association (GAMA); he served as President of the latter organization in 2008 and is currently serving once more on its Board of Directors and as one of its representatives to the New Mexico Medical Society Council. He chairs the board of directors of the GAMA Political Action Committee. Dr Brown has also been active in the ACCP and chaired the Sleep Network for that organization; he has chaired and/or served on multiple committees of the ATS and AASM. Dr Brown was a long-time member of the Editorial Board of CHEST, the official publication of the American College of Chest Physicians, and is an Associate Editor and Section Editor (Emerging Technologies) for the Journal of Clinical Sleep Medicine, co-editor of the Section on Sleep and Respiratory Neurobiology of Current Opinion in Pulmonary Medicine, and was co-editor of a 2017 volume of Sleep Medicine Clinics concerned with Advanced PAP Therapies and Non-invasive Ventilation. He is the author or co-author of 53 research reports, clinical guidelines, and official statements and 60 commentaries and editorials, all in peer reviewed journals, as well as 26 book chapters and has 6 additional publications in press. At the University of New Mexico (UNM), USA, Dr Brown has served as medical director of the UNM Health System sleep disorders centers and as senior vice chair of clinical affairs for the Department of Internal Medicine. He has served multiple terms on the UNM Faculty Senate, is currently co-chair of its Policy Committee and a member and past chair of its Health Sciences Center Council. He has served on the Faculty Senate Faculty and Staff Benefits Committee, Operations Committee, Governmental Relations Committee, and Business Council. For the State of New Mexico, Dr Brown is a member of the Polysomnography Practice Advisory Committee and was appointed to the Advisory Board for Respiratory Care in 2010; he has chaired this Committee since 2014. Winfried Johannes RanderathWinfried Johannes RanderathAfter his medical studies in 1987 at the University of Duesseldorf in Germany, Dr Randerath has entered the field of pneumology with a focus on respiratory and sleep medicine. He published over 300 national and international papers. He is a Fellow of the American Thoracic Society and the American College of Chest Physicians and was awarded the Meier-Ewert-Price of the German Dental Sleep Medicine Society. He is Secretary General of the German Society of Respiratory Medicine (DGP) since 2018 and has served as a board member of the German Society for Sleep Research and Sleep Medicine. He also chairs the Northern Westphalian Society of Sleep Medicine since 2009. Within ERS he served as Group Chair of group 4.02 Sleep and Control of Breathing from 2015–2018. He chaired multiple ERS Task Forces in the past and the present. Dr Randerath chaired the congress of the German Respiratory Society in 2018, the congress of the German Society for Sleep Research and Sleep Medicine in 2007 and 2014 and the Spring Meeting of the West German Respiratory Society in 2010. His main research activities are: differentiation of obstructive and central sleep apnoea, interaction of sleep apnoea and the heart, pulmonary intensive care, chronic respiratory failure. Peter J. BarryPeter J. BarryDr Peter J. Barry undertook specialist training in Respiratory and General Internal Medicine in the Republic of Ireland. Having worked as a Clinical Research Fellow in cystic fibrosis at St. Vincent's University Hospital, Dublin, he joined the University Hospital of South Manchester and is now a Consultant Respiratory Physician in the Manchester Adult Cystic Fibrosis Centre. He is an Honorary Senior Lecturer with the University of Manchester, UK. Dr Barry is interested in the clinical applications of novel CF therapies, and has been national and global PI on CFTR modulator trials. He has served as a clinical expert on NICE evaluations of new therapies in CF, and is the Co-Chair of the Manchester Cystic Fibrosis Conference and a member of the ECFS Scientific Committee. Barry J. PlantBarry J. PlantProfessor Barry J. Plant MD, FRCPI, MFSEM is a Consultant Respiratory Physician, Clinical Lead for Respiratory Medicine and the Director of the Adult CF Centre at Cork University Hospital (CUH)-University College Cork, Ireland, an executive member of the CF Registry of Ireland, the current chairman of the Medical and Scientific Council of CF Ireland, and an executive board member of ECFS. A University College Cork Medical Graduate (Honours), he dual trained in Respiratory and General Medicine in accordance with the Royal College of Physicians of Ireland and subsequently undertook a Fellowship in Pulmonary and Critical Medicine at the University of Washington, Seattle, USA, with a special interest in CF, where he remained until securing his current post in 2007. He is the current Chairperson for the Royal College of Physicians of Ireland's Clinical Advisory Group (CAG) for Cystic Fibrosis, a lead author of “Cystic Fibrosis: A Model of Care for Ireland” NCP CF 2019 and the Adult Chairperson for the CF Covid NCP CF working group 2020. Professor Plant's research group focuses on translational medicine. As part of this his group have actively engaged in funded work in the area of mHealth, eLearning and virtual reality experiences in lung disease to compliment Respiratory care and education. He has received research grant support from many funding agencies including coordinating an FP7 award (6 million euros over 3 years) from the EU commission, involving 14 partner sites across Europe and one in the USA. The project CFMATTERS completed a randomised multi-centre control trial of microbiome-derived antimicrobial treatments versus current empirical therapy. Simultaneously, parallel human host-pathogen interactions in sputa, human gut microflora analysis and evaluation of murine exacerbation models will be performed. Equally his research group have significant clinical and research experience in the area of CFTR modulation and Aging in CF. His group actively participate in many CF clinical trials and he has been a PI on ‘real-world’ implications of new inhaled antibiotic delivery systems multicenter groups. Recently Professor Plant was a Global PI on a triple therapy CFTR modulator in CF. He has been an invited speaker at a number of meetings including ATS, ERS, ECFC, Australasian CF Society, and an FDA meeting.